Dr Changlin Dou

R&D President, Chief Operating Officer, Executive Board Member at Shandong Boan Biotechnology Co., Ltd, China

Speaker

Dr. Changlin Dou is the founder of Boan Biotech. He established Boan’s discovery and CMC development platforms and has successfully brought 3 antibody products to market in China and 9 products to clinical development in China, US, Europe, and Japan. Prior to returning to China in 2012 to start Boan Biotech, Dr. Dou worked on cell line and process development at several leading biotechnology and life science companies, including Regeneron, Genentech, and Life Technologies. He obtained his BS degree from Peking University and PhD degree from State University of New York at Stony Brook and conducted postdoctoral research at Memorial Sloan-Kettering Cancer Center. Dr. Dou is an inventor of 17 issued patents and 12 pending patents and a corresponding author of multiple scientific publications.